Literature DB >> 20510738

Emerging studies of human HIV-specific antibody repertoires.

Mark D Hicar1, Spyros A Kalams, Paul W Spearman, James E Crowe.   

Abstract

There has been an explosion of interest in the human B cell response to HIV infection of late. Recent advances in techniques for isolation of human antibodies and antibody secreting cell lines have facilitated a rapid expansion in the number of antibodies available for study. Early analysis of these repertoires reveals interesting features of the HIV-specific antibody response. HIV-specific repertoires exhibit a high level of clonality in circulating cells, and high levels of somatic mutations within the antibody variable gene segments. It appears that many if not most antibodies in circulation bind to virus envelope conformations that are found only in complex oligomeric structures on virion particles or virus-like particles. The rapid isolation of large panels of novel human neutralizing antibodies promises to reveal new insights into the fundamental principles underlying antibody-mediated neutralization of HIV. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510738      PMCID: PMC2879399          DOI: 10.1016/j.vaccine.2010.02.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  37 in total

1.  Report on the AIDS Vaccine 2008 Conference.

Authors:  Galit Alter; Jintanat Ananworanich; Ralph Pantophlet; Ed P Rybicki; Luigi Buonaguro
Journal:  Hum Vaccin       Date:  2009-03-08

2.  HIV vaccine research: the way forward.

Authors:  Anthony S Fauci; Margaret I Johnston; Carl W Dieffenbach; Dennis R Burton; Scott M Hammer; James A Hoxie; Malcolm Martin; Julie Overbaugh; David I Watkins; Adel Mahmoud; Warner C Greene
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

3.  An HIV vaccine--challenges and prospects.

Authors:  Margaret I Johnston; Anthony S Fauci
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

4.  Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

Authors:  James M Binley; Elizabeth A Lybarger; Emma T Crooks; Michael S Seaman; Elin Gray; Katie L Davis; Julie M Decker; Diane Wycuff; Linda Harris; Natalie Hawkins; Blake Wood; Cory Nathe; Douglas Richman; Georgia D Tomaras; Frederic Bibollet-Ruche; James E Robinson; Lynn Morris; George M Shaw; David C Montefiori; John R Mascola
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

6.  Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

Authors:  David I Watkins; Dennis R Burton; Esper G Kallas; John P Moore; Wayne C Koff
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

7.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

8.  Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Authors:  Xiaocong Yu; Tshidi Tsibane; Patricia A McGraw; Frances S House; Christopher J Keefer; Mark D Hicar; Terrence M Tumpey; Claudia Pappas; Lucy A Perrone; Osvaldo Martinez; James Stevens; Ian A Wilson; Patricia V Aguilar; Eric L Altschuler; Christopher F Basler; James E Crowe
Journal:  Nature       Date:  2008-08-17       Impact factor: 49.962

9.  Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Authors:  Laura M Walker; Sanjay K Phogat; Po-Ying Chan-Hui; Denise Wagner; Pham Phung; Julie L Goss; Terri Wrin; Melissa D Simek; Steven Fling; Jennifer L Mitcham; Jennifer K Lehrman; Frances H Priddy; Ole A Olsen; Steven M Frey; Phillip W Hammond; Stephen Kaminsky; Timothy Zamb; Matthew Moyle; Wayne C Koff; Pascal Poignard; Dennis R Burton
Journal:  Science       Date:  2009-09-03       Impact factor: 47.728

Review 10.  Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

Authors:  Leonidas Stamatatos; Lynn Morris; Dennis R Burton; John R Mascola
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

View more
  7 in total

1.  Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.

Authors:  Hakimuddin Sojar; Sarah Baron; Jonathan T Sullivan; Meghan Garrett; Marlies M van Haaren; Jonathon Hoffman; Julie Overbaugh; Benjamin J Doranz; Mark D Hicar
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

2.  Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.

Authors:  Mark D Hicar; Xuemin Chen; Spyros A Kalams; Hakimuddin Sojar; Gary Landucci; Donald N Forthal; Paul Spearman; James E Crowe
Journal:  Mol Immunol       Date:  2015-12-31       Impact factor: 4.407

3.  Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity.

Authors:  Erin M Scherer; Robin A Smith; Cassandra A Simonich; Nixon Niyonzima; Joseph J Carter; Denise A Galloway
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

4.  Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein.

Authors:  Mark D Hicar; Xuemin Chen; Chidananda Sulli; Trevor Barnes; Jason Goodman; Hakimuddin Sojar; Bryan Briney; Jordan Willis; Valentine U Chukwuma; Spyros A Kalams; Benjamin J Doranz; Paul Spearman; James E Crowe
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

5.  Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.

Authors:  Nicole A Doria-Rose; Han R Altae-Tran; Ryan S Roark; Stephen D Schmidt; Matthew S Sutton; Mark K Louder; Gwo-Yu Chuang; Robert T Bailer; Valerie Cortez; Rui Kong; Krisha McKee; Sijy O'Dell; Felicia Wang; Salim S Abdool Karim; James M Binley; Mark Connors; Barton F Haynes; Malcolm A Martin; David C Montefiori; Lynn Morris; Julie Overbaugh; Peter D Kwong; John R Mascola; Ivelin S Georgiev
Journal:  PLoS Pathog       Date:  2017-01-04       Impact factor: 6.823

6.  Assessment of Antibody Interference of Enfuvirtide (T20) Function Shows Assay Dependent Variability.

Authors:  Michele Smith; Jonathon Hoffman; Hakimuddin Sojar; Ravikumar Aalinkeel; Chiu-Bin Hsiao; Mark Daniel Hicar
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

7.  Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies.

Authors:  Garnett Kelsoe; Laurent Verkoczy; Barton F Haynes
Journal:  Vaccines (Basel)       Date:  2014-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.